HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Central activation of the cholinergic anti-inflammatory pathway reduces surgical inflammation in experimental post-operative ileus.

AbstractBACKGROUND AND PURPOSE:
Electrical stimulation of the vagus nerve reduces intestinal inflammation following mechanical handling, thereby shortening post-operative ileus in mice. Previous studies in a sepsis model showed that this cholinergic anti-inflammatory pathway can be activated pharmacologically by central administration of semapimod, an inhibitor of p38 mitogen-activated protein kinase. We therefore evaluated the effect of intracerebroventricular (i.c.v.) semapimod on intestinal inflammation and post-operative ileus in mice.
EXPERIMENTAL APPROACH:
Mice underwent a laparotomy or intestinal manipulation 1 h after i.c.v. pre-treatment with semapimod (1 µg·kg(-1) ) or saline. Drugs were administered through a cannula placed in the left lateral ventricle 1 week prior to experimentation. Twenty-four hours after surgery, gastric emptying was measured using scintigraphy, and the degree of intestinal inflammation was assessed. Finally, activation of brain regions was assessed using quantitative immunohistochemistry for c-fos.
KEY RESULTS:
Intestinal manipulation induced inflammation of the manipulated intestine and significantly delayed gastric emptying, 24 h after surgery in saline-treated animals. Semapimod significantly reduced this inflammation and improved gastric emptying. Vagotomy enhanced the inflammatory response induced by intestinal manipulation and abolished the anti-inflammatory effect of semapimod. Semapimod but not saline induced a significant increase in c-fos expression in the paraventricular nucleus, the nucleus of the solitary tract and the dorsal motor nucleus of the vagus nerve.
CONCLUSIONS AND IMPLICATIONS:
Our findings show that i.c.v. semapimod reduces manipulation-induced intestinal inflammation and prevented post-operative ileus. This anti-inflammatory effect depends on central activation of the vagus nerve.
AuthorsFo The, C Cailotto, J van der Vliet, W J de Jonge, R J Bennink, R M Buijs, G E Boeckxstaens
JournalBritish journal of pharmacology (Br J Pharmacol) Vol. 163 Issue 5 Pg. 1007-16 (Jul 2011) ISSN: 1476-5381 [Electronic] England
PMID21371006 (Publication Type: Journal Article)
Copyright© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Hydrazones
  • Proto-Oncogene Proteins c-fos
  • semapimod
  • Acetylcholine
Topics
  • Acetylcholine (agonists)
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage, therapeutic use)
  • Brain (drug effects, metabolism)
  • Disease Models, Animal
  • Enteritis (etiology, immunology, metabolism, prevention & control)
  • Female
  • Gastric Emptying (drug effects)
  • Hydrazones (administration & dosage, therapeutic use)
  • Ileus (etiology, immunology, metabolism, prevention & control)
  • Injections, Intraventricular
  • Mice
  • Mice, Inbred BALB C
  • Motor Neurons (drug effects, metabolism)
  • Postoperative Complications (etiology, immunology, metabolism, prevention & control)
  • Proto-Oncogene Proteins c-fos (biosynthesis)
  • Vagotomy
  • Vagus Nerve (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: